


Another Name马昔腾坦,Maxititan,Opsumit,LuciMaci
IndicationsIt is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH, WHO Group 1) to reduce the risk of disease progression and hospitalization.
Reg No.03 L 1320/25
Inspection No.569-25
WhatsApp: